Growth Metrics

Vericel (VCEL) Common Equity (2016 - 2025)

Historic Common Equity for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $321.9 million.

  • Vericel's Common Equity rose 2500.7% to $321.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.9 million, marking a year-over-year increase of 2500.7%. This contributed to the annual value of $292.0 million for FY2024, which is 2921.64% up from last year.
  • Latest data reveals that Vericel reported Common Equity of $321.9 million as of Q3 2025, which was up 2500.7% from $306.8 million recorded in Q2 2025.
  • Vericel's Common Equity's 5-year high stood at $321.9 million during Q3 2025, with a 5-year trough of $140.2 million in Q1 2021.
  • Over the past 5 years, Vericel's median Common Equity value was $198.9 million (recorded in 2023), while the average stood at $216.3 million.
  • In the last 5 years, Vericel's Common Equity surged by 4042.53% in 2021 and then soared by 1246.08% in 2023.
  • Vericel's Common Equity (Quarter) stood at $170.5 million in 2021, then grew by 12.79% to $192.3 million in 2022, then grew by 17.52% to $226.0 million in 2023, then grew by 29.22% to $292.0 million in 2024, then increased by 10.24% to $321.9 million in 2025.
  • Its last three reported values are $321.9 million in Q3 2025, $306.8 million for Q2 2025, and $295.5 million during Q1 2025.